| Particulars |
| Company Name |
Alivus Life Sciences Ltd |
| Face Value |
2 |
| BSE Code |
543322 |
| Year End |
202503 |
| Full Year |
| Equity (Rs in Cr.) |
24.53 |
| B.V. Rs |
229.70 |
| Sales Rs in Cr. |
2,386.88 |
| NP Rs in Cr. |
485.63 |
| NP Var% |
3.00 |
| Div% |
250.00 |
| CPS Rs |
44.50 |
| EPS Rs |
39.60 |
| Traded Value(Rs in Lakhs) |
30.09 |
| 52 Week High |
1,335.00 |
| 52 Week Low |
821.00 |
| Price BSE |
1,001.00 |
| Price NSE |
1,001.00 |
| Market Capital(Rs in Cr.) |
12,278.24 |
| P/C Ratio |
22.50 |
| P/E Ratio |
25.30 |
| Price Vs.BV |
4.36 |
| Latest Quarter |
| Year End |
202503 |
| Sales Rs in Cr. |
649.55 |
| NP Rs in Cr. |
141.87 |
| NP Var % |
45.00 |
| Trailing Twelve Months |
| Year End |
202503 |
| Sales |
2,204.90 |
| OPM |
27.57 |
| NP |
423.50 |
| NP Var% |
3.02 |
| EPS |
39.60 |
| PE |
25.28 |
|